TZ-2 (Tirz)

TZ-2 (Tirz)

Price range: $35.00 through $115.00

TZ-2 (Tirz) is a high-purity dual incretin receptor agonist designed for advanced GLP-1 and GIP pathway research, supporting metabolic and insulin-sensitivity studies in laboratory settings.

SKU: TZ40 Category:

TZ-2 (Tirz) – Premium Research Peptide

TZ-2 (Tirz) is a premium-quality research peptide formulated for scientific investigation into metabolic regulation, insulin signaling, and incretin hormone pathways. As a dual GLP-1 and GIP receptor agonist, TZ-2 has become a significant focus of modern peptide research due to its potential role in supporting studies related to glucose metabolism, appetite regulation, and body composition.

Manufactured under strict quality standards and tested for purity, TZ-2 is intended exclusively for laboratory and research use. Researchers utilize TZ-2 in studies examining incretin receptor activity, metabolic adaptation, insulin sensitivity, and related physiological mechanisms.

Each vial undergoes rigorous quality control procedures to ensure consistency, purity, and reliability for research applications. The peptide is supplied in lyophilized form and should be handled only by qualified professionals within controlled laboratory environments.

Key Features

High-purity research-grade TZ-2 (Tirz)
Dual GLP-1 and GIP receptor agonist
Suitable for metabolic and insulin pathway research
Laboratory tested for purity and consistency
Lyophilized peptide for research applications
Intended strictly for scientific research use

Research Disclaimer

This product is intended for laboratory research purposes only. It is not intended for human consumption, medical use, diagnosis, treatment, or prevention of any disease. All research must be conducted by qualified professionals in compliance with applicable laws and regulations.

quantity

10MG, 15MG, 20MG, 30MG, 40MG, 60MG

Reviews

There are no reviews yet.

Be the first to review “TZ-2 (Tirz)”

Your email address will not be published. Required fields are marked *

Scroll to Top